Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug

Simple item page
dc.contributor.authorVilar-Gomez, Eduardo
dc.contributor.authorChalasani, Naga
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2019-08-22T19:33:40Z
dc.date.available2019-08-22T19:33:40Z
dc.date.issued2019
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationVilar-Gomez, E., & Chalasani, N. (2019). Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2019.06.032en_US
dc.identifier.urihttps://hdl.handle.net/1805/20525
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.cgh.2019.06.032en_US
dc.relation.journalClinical Gastroenterology and Hepatologyen_US
dc.rightsPublisher Policyen_US
dc.sourcePublisheren_US
dc.subjectNAFLDen_US
dc.subjectfibrosisen_US
dc.subjectcirrhosisen_US
dc.titleDaily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drugen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Vilar-Gomez_2019_daily.pdf
Size:
539.72 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works